Targeting of the Adenosine Receptors as a Novel Strategy for the Treatment of Arterial Hypertension

Journal of Neurology & Neurophysiology

doi 10.4172/2155-9562.1000243

Full Text

Abstract

Available in

Date

January 1, 2014

Authors

Yoshiyuki Shimizu

Shigeyuki Yamamoto

Publisher

OMICS Publishing Group

Related search

Adenosine Receptors as Drug Targets for Treatment of Pulmonary Arterial Hypertension

Frontiers in Pharmacology

English

Potential of Proteinase-Activated Receptors as a Novel Target for Treatment of Pulmonary Hypertension

Folia Pharmacologica Japonica

English

Targeting Proteasome-Associated Deubiquitinases as a Novel Strategy for the Treatment of Estrogen Receptor-Positive Breast Cancer

Cancer Research

Molecular Biology

English

Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council

English

Targeting Histones for Degradation in Cancer Cells as a Novel Strategy in Cancer Treatment

Science China Life Sciences

Molecular Biology

Environmental Science

Biological Sciences

English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy

English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy

English

Targeting the Metabolism of Leukemia Stem Cells as a Novel Therapeutic Strategy

Drugs in Context

Molecular Medicine

English

Future Perspectives for the Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension

English